Lucid Diagnostics (LUCD) EBIT Growth (1y) (2021 - 2026)
Lucid Diagnostics (LUCD) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 16.18% |
| 10 | Lucid Diagnostics | 176.13 Mn | 142.73 Mn | 55,000.00 | -12.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.45% |
| Mar 31, 2026 | 2.99% |
| Dec 31, 2025 | -13.22% |
| Sep 30, 2025 | -0.56% |
| Jun 30, 2025 | -1.72% |
| Mar 31, 2025 | -15.71% |
| Dec 31, 2024 | -8.05% |
| Sep 30, 2024 | -5.09% |
| Jun 30, 2024 | 3.38% |
| Mar 31, 2024 | 24.62% |
| Dec 31, 2023 | 23.52% |
| Sep 30, 2023 | 22.60% |
| Jun 30, 2023 | 20.81% |
| Mar 31, 2023 | -16.67% |
| Dec 31, 2022 | -33.22% |
| Sep 30, 2022 | -120.84% |
| Jun 30, 2022 | -143.15% |
| Mar 31, 2022 | -235.92% |
| Dec 31, 2021 | -311.59% |
| Sep 30, 2021 | -222.01% |